122 related articles for article (PubMed ID: 38065272)
41. A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure.
Bradley JM; Spaletra P; Li Z; Sharp TE; Goodchild TT; Corral LG; Fung L; Chan KWH; Sullivan RW; Swindlehurst CA; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H563-H570. PubMed ID: 29949382
[TBL] [Abstract][Full Text] [Related]
42. Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy.
Costantino S; Mengozzi A; Velagapudi S; Mohammed SA; Gorica E; Akhmedov A; Mongelli A; Pugliese NR; Masi S; Virdis A; Hülsmeier A; Matter CM; Hornemann T; Melina G; Ruschitzka F; Luscher TF; Paneni F
Cardiovasc Diabetol; 2023 Nov; 22(1):312. PubMed ID: 37957697
[TBL] [Abstract][Full Text] [Related]
43. Effect of liraglutide on the Janus kinase/signal transducer and transcription activator (JAK/STAT) pathway in diabetic kidney disease in db/db mice and in cultured endothelial cells.
Zitman-Gal T; Einbinder Y; Ohana M; Katzav A; Kartawy A; Benchetrit S
J Diabetes; 2019 Aug; 11(8):656-664. PubMed ID: 30575282
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of microRNA-150-5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose-treated cardiac fibroblasts.
Che H; Wang Y; Li Y; Lv J; Li H; Liu Y; Dong R; Sun Y; Xu X; Zhao J; Wang L
J Cell Physiol; 2020 Nov; 235(11):7769-7779. PubMed ID: 31710102
[TBL] [Abstract][Full Text] [Related]
45. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679
[TBL] [Abstract][Full Text] [Related]
46. Low-intensity pulsed ultrasound ameliorates cardiac diastolic dysfunction in mice: a possible novel therapy for heart failure with preserved left ventricular ejection fraction.
Monma Y; Shindo T; Eguchi K; Kurosawa R; Kagaya Y; Ikumi Y; Ichijo S; Nakata T; Miyata S; Matsumoto A; Sato H; Miura M; Kanai H; Shimokawa H
Cardiovasc Res; 2021 Apr; 117(5):1325-1338. PubMed ID: 32683442
[TBL] [Abstract][Full Text] [Related]
47. Exosomal microRNAs miR-30d-5p and miR-126a-5p Are Associated with Heart Failure with Preserved Ejection Fraction in STZ-Induced Type 1 Diabetic Rats.
Huang JP; Chang CC; Kuo CY; Huang KJ; Sokal EM; Chen KH; Hung LM
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886860
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of MEF2A prevents hyperglycemia-induced extracellular matrix accumulation by blocking Akt and TGF-β1/Smad activation in cardiac fibroblasts.
Chen X; Liu G; Zhang W; Zhang J; Yan Y; Dong W; Liang E; Zhang Y; Zhang M
Int J Biochem Cell Biol; 2015 Dec; 69():52-61. PubMed ID: 26482596
[TBL] [Abstract][Full Text] [Related]
49. Non-Invasive Local Acoustic Therapy Ameliorates Diabetic Heart Fibrosis by Suppressing ACE-Mediated Oxidative Stress and Inflammation in Cardiac Fibroblasts.
Weng L; Li L; Zhao K; Xu T; Mao Y; Shu H; Chen X; Chen J; Wu J; Guo X; Tu J; Zhang D; Sun W; Kong X
Cardiovasc Drugs Ther; 2022 Jun; 36(3):413-424. PubMed ID: 35156147
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.
Verma SK; Krishnamurthy P; Barefield D; Singh N; Gupta R; Lambers E; Thal M; Mackie A; Hoxha E; Ramirez V; Qin G; Sadayappan S; Ghosh AK; Kishore R
Circulation; 2012 Jul; 126(4):418-29. PubMed ID: 22705886
[TBL] [Abstract][Full Text] [Related]
51. Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses.
Li L; Luo W; Qian Y; Zhu W; Qian J; Li J; Jin Y; Xu X; Liang G
Phytomedicine; 2019 Jun; 59():152774. PubMed ID: 31009852
[TBL] [Abstract][Full Text] [Related]
52. NOD1 activation in cardiac fibroblasts induces myocardial fibrosis in a murine model of type 2 diabetes.
Val-Blasco A; Prieto P; Gonzalez-Ramos S; Benito G; Vallejo-Cremades MT; Pacheco I; González-Peramato P; Agra N; Terrón V; Delgado C; Martín-Sanz P; Boscá L; Fernández-Velasco M
Biochem J; 2017 Feb; 474(3):399-410. PubMed ID: 27803247
[TBL] [Abstract][Full Text] [Related]
53. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
[TBL] [Abstract][Full Text] [Related]
54. The ubiquitin ligase WWP1 contributes to shifts in matrix proteolytic profiles and a myocardial aging phenotype with diastolic heart.
Matesic LE; Freeburg LA; Snyder LB; Duncan LA; Moore A; Perreault PE; Zellars KN; Goldsmith EC; Spinale FG
Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H765-H774. PubMed ID: 32822210
[TBL] [Abstract][Full Text] [Related]
55. Targeting HDAC6 to treat heart failure with preserved ejection fraction in mice.
Ranjbarvaziri S; Zeng A; Wu I; Greer-Short A; Farshidfar F; Budan A; Xu E; Shenwai R; Kozubov M; Li C; Van Pell M; Grafton F; MacKay CE; Song X; Priest JR; Argast G; Mandegar MA; Hoey T; Yang J
Nat Commun; 2024 Feb; 15(1):1352. PubMed ID: 38409164
[TBL] [Abstract][Full Text] [Related]
56. Aldehyde dehydrogenase 2 augments adiponectin signaling in coronary angiogenesis in HFpEF associated with diabetes.
Roy B; Pan G; Giri S; Thandavarayan RA; Palaniyandi SS
FASEB J; 2022 Aug; 36(8):e22440. PubMed ID: 35815932
[TBL] [Abstract][Full Text] [Related]
57. Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli.
Engebretsen KV; Lunde IG; Strand ME; Waehre A; Sjaastad I; Marstein HS; Skrbic B; Dahl CP; Askevold ET; Christensen G; Bjørnstad JL; Tønnessen T
FEBS J; 2013 May; 280(10):2382-98. PubMed ID: 23480731
[TBL] [Abstract][Full Text] [Related]
58. Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.
Valero-Muñoz M; Li S; Wilson RM; Hulsmans M; Aprahamian T; Fuster JJ; Nahrendorf M; Scherer PE; Sam F
Circ Heart Fail; 2016 Jan; 9(1):e002724. PubMed ID: 26721917
[TBL] [Abstract][Full Text] [Related]
59. High-Choline Diet Exacerbates Cardiac Dysfunction, Fibrosis, and Inflammation in a Mouse Model of Heart Failure With Preserved Ejection Fraction.
Shuai W; Wen J; Li X; Wang D; Li Y; Xiang J
J Card Fail; 2020 Aug; 26(8):694-702. PubMed ID: 32417378
[TBL] [Abstract][Full Text] [Related]
60. The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.
Withaar C; Meems LMG; Markousis-Mavrogenis G; Boogerd CJ; Silljé HHW; Schouten EM; Dokter MM; Voors AA; Westenbrink BD; Lam CSP; de Boer RA
Cardiovasc Res; 2021 Jul; 117(9):2108-2124. PubMed ID: 32871009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
